Co-Diagnostics Statistics
Share Statistics
Co-Diagnostics has 31.93M shares outstanding. The number of shares has increased by 4.35% in one year.
| Shares Outstanding | 31.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 29.46M |
| Failed to Deliver (FTD) Shares | 488 |
| FTD / Avg. Volume | 0.46% |
Short Selling Information
The latest short interest is 208.70K, so 0.65% of the outstanding shares have been sold short.
| Short Interest | 208.70K |
| Short % of Shares Out | 0.65% |
| Short % of Float | 0.69% |
| Short Ratio (days to cover) | 2.63 |
Valuation Ratios
The PE ratio is -1.1 and the forward PE ratio is -1.
| PE Ratio | -1.1 |
| Forward PE | -1 |
| PS Ratio | 5.73 |
| Forward PS | 17.7 |
| PB Ratio | 0.45 |
| P/FCF Ratio | -1.66 |
| PEG Ratio | n/a |
Enterprise Valuation
Co-Diagnostics Inc. has an Enterprise Value (EV) of 27.10M.
| EV / Earnings | -0.77 |
| EV / Sales | 3.98 |
| EV / EBITDA | -0.65 |
| EV / EBIT | -0.63 |
| EV / FCF | -1.16 |
Financial Position
The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.81 |
| Quick Ratio | 10.52 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 0.97 |
| Cash Flow / Debt | -26.34 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.41% and return on capital (ROIC) is -44.49%.
| Return on Equity (ROE) | -0.41% |
| Return on Assets (ROA) | -0.37% |
| Return on Capital (ROIC) | -44.49% |
| Revenue Per Employee | 43.95K |
| Profits Per Employee | -227.95K |
| Employee Count | 155 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 2.51 |
Taxes
| Income Tax | -2.78M |
| Effective Tax Rate | 0.07 |
Stock Price Statistics
The stock price has increased by -27.19% in the last 52 weeks. The beta is -0.85, so Co-Diagnostics 's price volatility has been lower than the market average.
| Beta | -0.85 |
| 52-Week Price Change | -27.19% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 1.2 |
| Relative Strength Index (RSI) | 30.96 |
| Average Volume (20 Days) | 105.92K |
Income Statement
In the last 12 months, Co-Diagnostics had revenue of $6.81M and earned -$35.33M in profits. Earnings per share was $-1.2.
| Revenue | 6.81M |
| Gross Profit | 2.63M |
| Operating Income | -42.71M |
| Net Income | -35.33M |
| EBITDA | -41.48M |
| EBIT | -42.71M |
| Earnings Per Share (EPS) | -1.2 |
Balance Sheet
The company has $14.92M in cash and $2.99M in debt, giving a net cash position of $11.93M.
| Cash & Cash Equivalents | 14.92M |
| Total Debt | 2.99M |
| Net Cash | 11.93M |
| Retained Earnings | 4.60M |
| Total Assets | 72.38M |
| Working Capital | 34.31M |
Cash Flow
In the last 12 months, operating cash flow was -$22.08M and capital expenditures -$1.37M, giving a free cash flow of -$23.45M.
| Operating Cash Flow | -22.08M |
| Capital Expenditures | -1.37M |
| Free Cash Flow | -23.45M |
| FCF Per Share | -0.8 |
Margins
Gross margin is 38.57%, with operating and profit margins of -626.92% and -518.68%.
| Gross Margin | 38.57% |
| Operating Margin | -626.92% |
| Pretax Margin | -559.46% |
| Profit Margin | -518.68% |
| EBITDA Margin | -608.86% |
| EBIT Margin | -626.92% |
| FCF Margin | -344.2% |
Dividends & Yields
CODX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -144.58% |
| FCF Yield | -88.27% |
Analyst Forecast
The average price target for CODX is $1.5, which is 80.7% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.5 |
| Price Target Difference | 80.7% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 2 |